Yasir Khan | Biology and Life Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Research Excellence Award

Yasir Khan
Aligarh Muslim University, India
Yasir Khan
Affiliation Aligarh Muslim University
Country India
Scopus ID 56673715100
Documents 12
Citations 306
h-index 8
Subject Area Biology and Life Sciences
Event International Forensic Scientist Awards
ORCID 0000-0001-9277-7164

Yasir Khan is an Indian researcher affiliated with Aligarh Muslim University whose academic work spans parasitology, immunomodulation, bone biology, and translational biomedical sciences. His research activities include investigations into helminth-derived immunomodulatory proteins, inflammatory disease pathways, metabolomics, and osteogenic biology. Through interdisciplinary collaboration and peer-reviewed scientific publications, Khan has contributed to research areas associated with autoimmune disease modulation, anti-inflammatory therapeutics, and experimental bone biology.[1] His scholarly profile reflects an integration of molecular parasitology with biomedical innovation, particularly in relation to immune-mediated disorders and skeletal health.[2]

Abstract

This academic article presents a professional overview of the scientific profile and research contributions of Yasir Akhtar Khan in the fields of parasitology, immunomodulation, inflammatory disease biology, and bone research. His work has explored the therapeutic and immunological significance of helminth-derived molecules, osteogenic mechanisms, metabolomics, and anti-inflammatory pharmacological studies. The article also evaluates his publication record, citation metrics, and scholarly impact within Biology and Life Sciences. Particular emphasis is placed on his interdisciplinary investigations involving autoimmune diseases, bone metabolism, and experimental therapeutics.[3]

Keywords

  • Helminth Immunomodulation
  • Autoimmune Diseases
  • Bone Biology
  • Parasitology
  • Inflammatory Disease Research
  • Metabolomics

Introduction

Contemporary biomedical research increasingly depends on interdisciplinary approaches that connect molecular biology, immunology, pharmacology, and translational medicine. Researchers investigating parasitic immunomodulation and inflammatory regulation have contributed significantly to understanding the interaction between pathogens and host immune systems. Within this scientific context, Yasir Akhtar Khan has developed a research portfolio focused on immune modulation, skeletal biology, and inflammatory disease mechanisms.[4]

His work has incorporated laboratory-based investigations, pharmacological evaluations, and metabolomic analyses aimed at understanding disease progression and therapeutic modulation. The combination of parasitology and bone biology in his research profile demonstrates an integrative scientific methodology that addresses both mechanistic and translational biomedical questions.[5]

Research Profile

Yasir Akhtar Khan has been associated with Aligarh Muslim University since 2018 in teaching and research activities related to parasitology and zoology. Prior to this appointment, he conducted research at the Central Drug Research Institute in Lucknow, India, where his work included investigations in endocrinology and experimental bone biology.[1]

His doctoral studies at Aligarh Muslim University focused on molecular and immunoparasitology, establishing a scientific foundation for subsequent investigations into helminth-derived immunomodulatory proteins and inflammatory disease pathways. His research interests include helminth immunomodulation, autoimmune disorders, parasitology, osteogenic signaling, and inflammatory regulation.[2]

The researcher has also been associated with externally funded projects, including investigations supported by the Science and Engineering Research Board in India. These projects addressed immune response modulation and pathological regulation in rheumatoid arthritis models using Fasciola gigantica-derived proteins.[6]

Research Contributions

Among Khan’s notable scientific contributions is his work investigating the protective role of Fasciola helminth defense molecule-1 in experimental arthritis models. The study explored osteoclast inhibition and demonstrated potential implications for inflammatory bone diseases without broad systemic immune suppression.[7]

Additional contributions include studies related to osteopenia reversal, bone marrow adipogenesis, fracture healing, and osteo-angiogenic regulation in experimental models. His work on anti-hypertensive and hemorheologic drugs further examined vascular function and osteogenic effects associated with bone health in hypertensive animal models.[8]

Khan has also participated in metabolomics and phytochemical investigations involving medicinal plants such as Aegle marmelos and Commiphora madagascariensis. These studies examined antioxidant and anti-inflammatory activities using in vitro and in vivo models, contributing to the understanding of bioactive plant compounds in biomedical research.[9]

His interdisciplinary scholarship additionally includes scientific literature related to microbial nanotechnology and protozoa-mediated nanoparticle synthesis, reflecting broader engagement with emerging biomedical technologies and translational applications.[10]

Publications

  • Metabolomics and anti-inflammatory activity of Commiphora madagascariensis jacq. leaves extract using in vitro and in vivo models, Journal of Chromatography B (2024).
  • The Role of Osteogenic Effect and Vascular Function in Bone Health in Hypertensive Rats: A Study of Anti-hypertensive and Hemorheologic Drugs, Calcified Tissue International (2023).
  • Metabolite Profiling, Isolation of Cyclic Polyols, Antioxidant and Anti-inflammatory Activities of Aegle Marmelos, Journal of Herbs, Spices & Medicinal Plants (2021).
  • Protozoa: As Emerging Candidates for the Synthesis of NPs, Microbial Nanotechnology: Green Synthesis and Applications (2021).
  • Fasciola helminth defense molecule‐1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response, The FASEB Journal (2020).

Research Impact

The research output of Yasir Akhtar Khan demonstrates measurable scholarly visibility through indexed publications, citation metrics, and interdisciplinary collaborations. His Scopus profile reports more than 300 citations across peer-reviewed publications with an h-index of 8, indicating sustained academic engagement within biomedical and life science disciplines.[1]

The translational orientation of his work is particularly evident in studies concerning inflammatory regulation, skeletal disease models, and therapeutic immunomodulation. Research findings associated with helminth-derived biomolecules have contributed to ongoing discussions regarding alternative approaches to inflammatory disease treatment and immune regulation.[7]

His investigations into metabolomics and phytopharmacology further support scientific efforts to identify biologically active compounds with therapeutic relevance. These interdisciplinary contributions reinforce the relevance of his research within both academic and applied biomedical contexts.[9]

Award Suitability

Yasir Akhtar Khan’s research profile aligns with the objectives of the International Forensic Scientist Awards through his sustained contributions to biomedical research, experimental therapeutics, and interdisciplinary life sciences. His scientific investigations combine immunology, parasitology, metabolomics, and bone biology in a manner that demonstrates methodological rigor and translational relevance.[3]

The diversity of his publication portfolio, externally funded research activities, and citation record indicate active participation in internationally visible scientific scholarship. His contributions to immune modulation and inflammatory disease research further illustrate scientific innovation and cross-disciplinary integration that are consistent with criteria commonly associated with research excellence recognition.[6]

Conclusion

Yasir Akhtar Khan has established a scholarly profile characterized by interdisciplinary biomedical research involving parasitology, immunomodulation, bone biology, and metabolomics. His academic contributions reflect sustained engagement with translational scientific questions and experimental disease models. Through peer-reviewed publications, funded research projects, and measurable citation impact, he has contributed to the advancement of knowledge in Biology and Life Sciences. His research activities and scientific outputs collectively support recognition within international academic and research award frameworks.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Yasir Akhtar Khan, Author ID 56673715100. Scopus.
    www.scopus.com/authid/detail.uri?authorId=56673715100
  2. ORCID. (n.d.). Yasir Akhtar Khan ORCID Profile.
    orcid.org/0000-0001-9277-7164
  3. International Forensic Scientist Awards. (n.d.). Research Excellence Award Program Information.
    forensicscientist.org
  4. Khan, Y. A. et al. (2020). Fasciola helminth defense molecule‐1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response. The FASEB Journal.
    https://doi.org/10.1096/fj.201901480rr
  5. Khan, Y. A. et al. (2019). Reversal of Osteopenia in Ovariectomized Rats by Pentoxifylline. Calcified Tissue International.
    https://doi.org/10.1007/s00223-019-00567-4
  6. Science and Engineering Research Board. (2018). Modulation of systemic immune response and pathology in DBA-1 mouse model of rheumatoid arthritis by Fasciola gigantica derived immunomodulatory proteins.
  7. Khan, Y. A. et al. (2020). Experimental arthritis modulation through helminth defense molecules. The FASEB Journal.
    https://doi.org/10.1096/fj.201901480rr
  8. Khan, Y. A. et al. (2023). The Role of Osteogenic Effect and Vascular Function in Bone Health in Hypertensive Rats. Calcified Tissue International.
    https://doi.org/10.1007/s00223-023-01170-4
  9. Khan, Y. A. et al. (2024). Metabolomics and anti-inflammatory activity of Commiphora madagascariensis jacq. leaves extract. Journal of Chromatography B.
    https://doi.org/10.1016/j.jchromb.2024.124214
  10. Khan, Y. A. et al. (2021). Protozoa: As Emerging Candidates for the Synthesis of NPs. Microbial Nanotechnology: Green Synthesis and Applications.
    https://doi.org/10.1007/978-981-16-1923-6_8

Hongyong Zhang | Biology | Best Researcher Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Hongyong Zhang | Biology | Best Researcher Award

Central People’s Hospital of Zhanjiang | China

Dr. Hongyong Zhang is an accomplished Associate Professor at Guangdong Medical University, based at the Central People’s Hospital of Zhanjiang. With an extensive background in developmental biology, molecular reproduction, and gene regulation, he has significantly contributed to the understanding of reproductive mechanisms and genetic engineering. His innovative research, particularly in mammalian oocyte development and gene editing using CRISPR/Cas9, continues to pave the way for breakthroughs in regenerative medicine and reproductive biology.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Strong Academic Background and Postdoctoral Training
    Dr. Zhang has completed his doctoral studies in developmental biology at the Institute of Zoology, Chinese Academy of Sciences, one of China’s premier research institutions, followed by a long postdoctoral tenure until 2019. This foundation indicates deep training in life sciences and developmental biology.

  • Progressive Academic Career
    He currently holds an Associate Professor position at Guangdong Medical University, demonstrating academic growth and recognition. Prior engagements at prominent institutions like the Shenzhen PKU-HKUST Medical Center further underscore his institutional reputation.

  • Independent Research Grants as PI
    Dr. Zhang has secured multiple national and regional research projects, such as:

    • NSFC Youth Science Fund (2024–2026)

    • Guangdong Basic and Applied Basic Research Foundation (2022–2025)

    • China Postdoctoral Science Foundation (2020–2022)
      This shows his ability to attract competitive funding and lead research independently.

  • Strong Publication Record in High-Impact Journals
    Notable publications include:

    • EMBO Molecular Medicine (impactful and reputed in biomedical research)

    • Frontiers in Cell and Developmental Biology

    • Journal of Cellular Physiology

    • Toxicology
      These reflect both quality and diversity in research topics including oocyte maturation, spindle checkpoint regulation, cancer cell biology, and blastocyst complementation.

🎓 Education

Dr. Zhang embarked on his academic journey at Northeast Agricultural University (2009–2013), where he earned a degree in Biological Sciences. He then pursued a PhD in Developmental Biology at the Institute of Zoology, Chinese Academy of Sciences (2013–2019), where he delved into molecular mechanisms guiding embryonic and reproductive development in animals.

🧪 Experience

Following his doctoral studies, Dr. Zhang expanded his research horizon through prestigious postdoctoral work (2013–2019) at the Institute of Zoology, Chinese Academy of Sciences. He later contributed as a researcher at the Shenzhen Peking University–Hong Kong University of Science and Technology Medical Center (2020–2022). Since July 2022, he has held a faculty position as Associate Professor at Guangdong Medical University, where he actively leads independent research projects in developmental biology and gene regulation.

🔬 Research Interests On Biology

Dr. Zhang’s research interests revolve around the molecular regulation of oocyte maturation, chromatin accessibility, meiotic progression, and blastocyst complementation. He is also passionate about the development of gene-edited animal models for studying neurodegenerative and metabolic diseases. His focus on GPER1 gene editing, Fosl2 mechanisms, and spindle checkpoint regulation underpins his impactful contributions to reproductive and regenerative medicine.

🏆 Awards

Dr. Zhang has received multiple national and regional grants as Principal Investigator, reflecting his scientific excellence and innovation. These include:

  • NSFC Youth Science Fund Project (2024–2026) on Fosl2 mechanisms

  • GDBR Youth Science Fund Project (2022–2025) on CyclinB2/CDK1 regulation

  • China Postdoctoral Science Foundation General Fund (2020–2022) for CRISPR/Cas9-based GPER1 knockout pig models

📚 Publications

Dr. Zhang has published high-impact papers in leading scientific journals. Below is a list of selected publications with full citation and links:

  1. Zhang H-Y, et al. Rescuing ocular development in an anophthalmic pig by blastocyst complementation. EMBO Molecular Medicine, 2018, 10(12): e8861.

    Cited by: 120 articles

  2. Zhang H-Y, Li J, Ouyang Y-C, et al. Cell Division Cycle 5-Like Regulates Metaphase-to-Anaphase Transition in Meiotic Oocyte. Frontiers in Cell and Developmental Biology, 2021, 9: 671685.

    Cited by: 47 articles

  3. Guan Y-T, Zhang C, Zhang H-Y, et al. Primary cilia: Structure, dynamics, and roles in cancer cells and tumor microenvironment. Journal of Cellular Physiology, 2023, 238(8): 1788–1807.

    Cited by: 15 articles

  4. Chen H, Gong S, Zhang H-Y, et al. From the regulatory mechanism of TFEB to its therapeutic implications. Cell Death Discovery, 2024, 10(1): Full Text.

    Cited by: 5 articles

  5. Zhang H-Y, Ouyang Y-C, Li J, et al. Gefitinib reduces oocyte quality by disturbing meiotic progression. Toxicology, 2021, 452: 152705.

    Cited by: 32 articles

🧾 Conclusion

With a strong foundation in molecular biology and developmental genetics, Dr. Hongyong Zhang exemplifies scientific excellence through his research, mentorship, and academic service. His pioneering work in oocyte biology, chromatin regulation, and gene editing has earned him a reputable place in the field, along with a robust publication record and competitive research funding. His dedication makes him a deserving nominee for any prestigious research award in biomedical sciences.

Xiuqin Bao | Biology | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Xiuqin Bao | Biology | Best Researcher Award

Guangdong Women and Children Hospital | China

Dr. Xiuqin Bao is a dedicated Associate Research Fellow specializing in medical genetics, with a strong background in epigenetic regulation and prenatal diagnostics. Her work focuses on developing innovative genetic therapies, particularly for blood disorders like β-thalassemia. She has co-authored multiple high-impact publications and contributed to significant research grants.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Strong Research Background:

    • Ph.D. in Genetics with a high GPA (3.8/4.0).

    • Focused research on β-thalassemia and γ-globin reactivation, a critical area in genetic medicine.

    • Published 8 papers, including multiple first/co-first author contributions in high-impact journals (IF 9.4–11.025).

  • Innovative Contributions:

    • Developed CRISPR-Cas9 editing strategies for HBG2 promoter activation.

    • Identified DNA methylation biomarkers for γ-globin reactivation.

    • Co-invented a ddPCR-based assay for α-globin gene CNV detection (patent holder).

  • Research Leadership & Funding:

    • Secured two major funded projects as Principal Investigator (total ¥350K).

    • Contributed to a ¥5.4M National Key R&D Program.

    • Recognized as Guangdong Outstanding Young Scholar (2024–2027).

  • Clinical & Technical Expertise:

    • Handles 500+ clinical cases annually with a 99% diagnostic accuracy.

    • Expertise in CRISPR, omics, and bioinformatics.

Education 🎓

Dr. Bao earned her Ph.D. and M.S. in Genetics from Southern Medical University (2015–2020), where she investigated the epigenetic regulation of γ-globin reactivation in β-thalassemia. She also holds a B.S. in Biopharmaceuticals (2011–2015) and was recognized with multiple academic excellence awards, including the First-Class Academic Scholarship.

Experience 💼

Currently serving as a Clinical Laboratory Technologist at Guangdong Women and Children Hospital, Dr. Bao conducts advanced prenatal diagnostic testing for thalassemia. She previously led epigenetic research projects as a Doctoral Researcher at Southern Medical University, contributing to groundbreaking discoveries in DNA methylation biomarkers and CRISPR-Cas9 editing for γ-globin activation.

Research Interests On Biology 🔬

Dr. Bao’s primary research focus is on the genetic and epigenetic mechanisms underlying hereditary blood disorders. She is particularly interested in using CRISPR gene-editing technology to reactivate fetal hemoglobin, offering potential therapeutic strategies for β-thalassemia. Her work also extends to biomarker discovery for precision medicine applications.

Awards 🏆

Dr. Bao has received several prestigious awards, including:

  • Guangdong Outstanding Young Scholar (2024–2027)
  • First-Class Academic Scholarships (2016, 2017, 2022)
  • Outstanding Communist Party Member (2018–2019) Her contributions to medical genetics have been recognized nationally and internationally.

Publications 📚

Dr. Bao has authored numerous high-impact publications, including:

  • “Activation of γ-globin expression by LncRNA-mediated ERF promoter hypermethylation in β-thalassemia”​

    • Co-authors: Yuanyi Gao, Zhongju Wang, Yuhua Ye, Diyu Chen, Yangjin Zuo, Cunyou Zhao, Xiangmin Xu​

    • Publication Year: 2024​

  • “DNA methylation patterns of β-globin cluster in β-thalassemia patients”​

    • Co-authors: Yangjin Zuo, Diyu Chen, Cunyou Zhao​

    • Publication Year: 2020​

    • Citations: 7​

  • “Abnormal hemoglobin anti-Lepore Hong Kong compound with β⁰-thalassemia ameliorate thalassemia severity when co-inherited with α-thalassemia”​

    • Co-authors: Jicheng Wang, Danqing Qin, Cuize Yao, Jie Liang, Kailing Liang, Li Du​

    • Publication Year: 2024​

  • “Severe fetal anemia and hydrops fetalis associated with compound heterozygosity for Hb Zurich-Albisrieden (HBA2:c.178G>C) and Hb Quong Sze (HBA2:c.377T>C)”​

    • Co-authors: Li Du, Wei He, Danqing Qin, Jicheng Wang, Ying Xiong, Xiaomei Shi, Hongke Ding, Cuize Yao, Jing Wu​

    • Publication Year: 2021​

  • “Identification and characterization of CHD4-associated eRNA as a novel modulator of fetal hemoglobin levels in β-thalassemia”

    • Co-authors: Not specified​

    • Publication Year: 2024​

    • Citations: 1​

  • “Two novel deletion mutations in β-globin gene cause β-thalassemia trait in two Chinese families”​

    • Co-authors: Danqing Qin, Jicheng Wang, Jing Chen, Cuize Yao, Jie Liang, Kailing Liang, Yixia Wang, Yousheng Wang, Li Du, Aihua Yin​

    • Publication Year: 2023​

  • “Different effects of anxiety and avoidance dimensions of attachment on interpersonal trust: A multilevel meta-analysis”​

    • Co-authors: Song Li, Yaoyao Zhang, Qingting Tang, Xu Chen​

    • Publication Year: 2022​

Conclusion 📝

Dr. Xiuqin Bao is a leading researcher in medical genetics, whose work in epigenetic modulation and gene therapy holds great promise for the future of hereditary blood disorder treatments. Through her extensive research, publications, and clinical expertise, she continues to contribute significantly to the advancement of genetic medicine.

Yiyao Cao | Biology | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Dr. Yiyao Cao | Biology | Best Researcher Award

Prof. Dr | Zhejiang Provincial Center for Disease Control and Prevention | China

Prof. Dr. Yiyao Cao is a distinguished expert in radiation detection and dose assessment, serving at the Zhejiang Provincial Center for Disease Control and Prevention. With a Doctor of Medicine (M.D.) degree and extensive expertise in radiation protection, Dr. Cao is a dedicated researcher addressing public concerns related to nuclear safety and environmental health. Her contributions have significantly advanced our understanding of the health implications of nuclear power operations.

Profile

Scopus

Strengths for the Awards

  • Specialized Research Focus: Dr. Cao’s expertise in radiation detection and dose assessment, coupled with her significant contribution to assessing radioactivity levels (Tritium and Carbon-14), demonstrates a niche and impactful research domain.
  • Research Output:
    • Published impactful research: The study on Tritium and Carbon-14 around San’ao Nuclear Power Plant highlights public health relevance.
    • Indexed Journals: Contributions to SCI-indexed journals signify the quality of her publications.
  • Innovative and Public Health Relevance:
    • The research addresses public concerns regarding nuclear power plant emissions, showcasing practical applications of findings.
    • Demonstrates a commitment to safeguarding community health through scientific evaluation.
  • Educational and Professional Credentials:
    • Holding an M.D. and leading research projects at the Zhejiang Provincial Center for Disease Control and Prevention indicate her academic and professional caliber.

Education 🎓

Dr. Cao earned her Doctor of Medicine (M.D.) degree, specializing in radiation detection and dose assessment. Her rigorous academic background has laid a strong foundation for her impactful research and innovations in radiation protection and nuclear safety.

Experience 🏢

Prof. Dr. Cao has accumulated years of professional expertise in radiation detection and public health. She has conducted critical studies to evaluate tritium and carbon-14 levels in food near nuclear power plants, ensuring environmental safety. Her leadership at the Zhejiang Provincial CDC reflects her commitment to advancing public health through research and practical applications.

Research Interests On Biology🔬

Dr. Cao focuses on radiation detection and dose assessment, with a special interest in environmental safety related to nuclear power operations. Her work assesses the risks posed by tritium and carbon-14, addressing public health concerns and guiding regulatory standards.

Awards 🏆

Award Nomination: Best Researcher Award
Dr. Cao has been nominated for her groundbreaking contributions to radiation protection research. Her studies have influenced health risk assessments and safety protocols in nuclear power operations.

Publications 📚

  • Efficient separation of Th(IV) from highly acidic solution by microporous resin materials containing two novel phenanthroline phosphonates
    Authors: Xu, L., Zou, Y., Dai, G., Pu, N., Zou, H.
    Year: 2025
    Citations: 0
  • Radon concentration and related employees’ chromosome aberration and micronuclei in subways in a city of Zhejiang Province
    Authors: Xuan, Z., Huang, X., Lai, Z., Zhang, D., Nie, J.
    Year: 2024
    Citations: 0
  • Development and application of UPLC-Q-Orbitrap HRMS methods for the determination of eight metabolites of p-chloronitrobenzene in human urine
    Authors: Wang, P., Xu, Q., Zou, H., Wang, J., Cao, Y.
    Year: 2024
    Citations: 0
  • Determination and human health risk assessment of TFWT, OBT and carbon-14 in seafood around Qinshan Nuclear Power Plant
    Authors: Ma, X., Cao, Y., Zheng, T., Ren, H.
    Year: 2024
    Citations: 1
  • Manganese dioxide decorated kiwi peel powder for efficient removal of lead from aqueous solutions, blood and Traditional Chinese Medicine extracts
    Authors: Gong, H., Cao, Y., Zeng, W., Kai, G., Qian, J.
    Year: 2024
    Citations: 0
  • Achievements in Preparation of Cyclodextrin–Based Porous Materials for Removal of Pollutants
    Authors: Bao, K., Zhang, A., Cao, Y., Xu, L.
    Year: 2024
    Citations: 1
  • Recent progresses in analytical method development for 210Pb in environmental and biological samples
    Authors: Ren, H., Gong, X., Zhou, L., Wang, P., Cao, Y.
    Year: 2024
    Citations: 0
  • Determination of carbon-14 in marine biota using oxidation combustion and gel suspension liquid scintillation counting
    Authors: Cao, Y., Qian, Y., Ren, H., Xie, Y., Ji, Y.
    Year: 2024
    Citations: 2
  • Establishment of OBT/TFWT dataset in seafood in Zhejiang province, China
    Authors: Gong, X., Huang, W., Cao, Y., Wang, P., Ren, H.
    Year: 2024
    Citations: 0
  • Model prediction of radioactivity levels in the environment and food around the world’s first AP 1000 nuclear power unit
    Authors: Wang, P., Huang, W., Zou, H., Xuan, Z., Cao, Y.
    Year: 2024
    Citations: 0

Conclusion ✅

Prof. Dr. Yiyao Cao’s work exemplifies dedication to public health and environmental safety. Through her expertise in radiation detection and dose assessment, she contributes to the well-being of communities and sets high standards in research and practice. Her achievements underscore her suitability for the Best Researcher Award.